| 000 | 01872 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517172834.0 | ||
| 264 | 0 | _c20180611 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1555-905X | ||
| 024 | 7 |
_a10.2215/CJN.02510317 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSise, Meghan E | |
| 245 | 0 | 0 |
_aEffect of Sofosbuvir-Based Hepatitis C Virus Therapy on Kidney Function in Patients with CKD. _h[electronic resource] |
| 260 |
_bClinical journal of the American Society of Nephrology : CJASN _cOct 2017 |
||
| 300 |
_a1615-1623 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuminuria _xcomplications |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSofosbuvir _xadverse effects |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBackman, Elke | |
| 700 | 1 | _aOrtiz, Guillermo A | |
| 700 | 1 | _aHundemer, Gregory L | |
| 700 | 1 | _aUfere, Nneka N | |
| 700 | 1 | _aChute, Donald F | |
| 700 | 1 | _aBrancale, Joseph | |
| 700 | 1 | _aXu, Dihua | |
| 700 | 1 | _aWisocky, Jessica | |
| 700 | 1 | _aLin, Ming V | |
| 700 | 1 | _aKim, Arthur Y | |
| 700 | 1 | _aThadhani, Ravi | |
| 700 | 1 | _aChung, Raymond T | |
| 773 | 0 |
_tClinical journal of the American Society of Nephrology : CJASN _gvol. 12 _gno. 10 _gp. 1615-1623 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2215/CJN.02510317 _zAvailable from publisher's website |
| 999 |
_c27538359 _d27538359 |
||